TRUP:NSD-Trupanion Inc. (USD)

EQUITY | Insurance - Specialty | NASDAQ Global Market

Last Closing

USD 47.08

Change

0.00 (0.00)%

Market Cap

USD 0.50B

Volume

1.08M

Analyst Target

USD 57.20
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Trupanion Inc with its subsidiaries is a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs throughout the United States, Canada and Puerto Rico.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Insurance - Specialty

Symbol Name Price(Change) Market Cap
ACT Enact Holdings Inc

-0.16 (-0.44%)

USD 5.62B
NMIH NMI Holdings Inc

-0.58 (-1.39%)

USD 3.27B
AMSF AMERISAFE Inc

+0.09 (+0.18%)

USD 0.94B
TIPT Tiptree Inc

+0.26 (+1.32%)

USD 0.72B
ITIC Investors Title Company

+4.84 (+2.14%)

USD 0.43B
JRVR James River Group Holdings Ltd

-0.09 (-1.35%)

USD 0.26B
ICCH ICC Holdings Inc

-0.08 (-0.35%)

USD 0.07B

ETFs Containing TRUP

PETZ:LSE 10.04 % 0.00 %

N/A

N/A
KATZ:XETRA 8.62 % 0.00 %

N/A

N/A
PETZ:SW 8.62 % 0.00 %

N/A

N/A
ISMD Inspire Small/Mid Cap Imp.. 0.29 % 0.62 %

+0.22 (+0%)

USD 0.19B

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Specialty) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 54.31% 100% F 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.31% 100% F 91% A-
Trailing 12 Months  
Capital Gain 57.67% 100% F 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.67% 100% F 89% A-
Trailing 5 Years  
Capital Gain 68.99% 75% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.99% 50% F 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 26.00% 75% C 81% B-
Dividend Return 26.00% 75% C 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 100.02% 25% F 18% F
Risk Adjusted Return 25.99% 38% F 60% D-
Market Capitalization 0.50B 75% C 79% B-

Key Financial Ratios

  Ratio vs. Industry/Classification (Insurance - Specialty) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 1,484.60 13% 0%
Price/Book Ratio 6.49 13% 18%
Price / Cash Flow Ratio 106.51 13% 2%
Price/Free Cash Flow Ratio 198.08 50% 2%
Management Effectiveness  
Return on Equity -6.36% 13% 52%
Return on Invested Capital -9.99% 13% 38%
Return on Assets -1.18% 13% 53%
Debt to Equity Ratio 42.01% 50% 46%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector